PR Newswire BiotechOriginal article
Empyrean Medical Systems Submits its Bespoke Vektra™ Beam Sculpting Radiation Therapy System to FDA
RegulatoryVektraPositive
AI Analysis
Summary
Empyrean Medical Systems announced it has submitted a 510(k) premarket notification to the FDA for its Vektra beam-sculpting radiation therapy system for brachytherapy and IORT. The filing is intended to advance the system toward clinical entry.
Outcome Details
510(k) premarket notification submitted to the FDA for the Vektra radiation therapy system; no FDA decision yet.
Importance:4/10
Sentiment:
0.30
510(k)medical deviceradiation therapybrachytherapyIORTFDA submission
Read the original article
Published by PR Newswire Biotech on October 19, 2026 2:55 PM